NEWSROOM
Blog
SKYX to Collaborate with EGLO, European World Leading Design and Manufacturer of Decorative Lighting and Ceiling Fans
The Collaboration Provides for the Joint Exploration and Product Development Potential for European and International markets for leveraging SKYX’s Technology, Product and Manufacturing Expertise of
ANEW MEDICAL, INC. Appoints New CFO
New York, NY, August 19, 2024 – ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a U.S.-based biotechnology company focused on developing cell and
Sono-Tek to Present at August 20th Virtual Investor Summit Microcap Event
MILTON, NY, August 15, 2024 — Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of ultrasonic coating systems, announced today that it will be
ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases
Issuance of the Klotho gene-therapy patent will be instrumental in protecting ANEW’s IP for development and commercialization in the U.S. New York, NY, August 15,
AmpliTech Group Reports Q2 Revenue of $2.5M with 1.05M Gross Profits and 42% Gross Margins
Hauppauge, NY, August 14, 2024 – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public
American Shared Hospital Services Reports Strong Second Quarter 2024 Financial Results
SAN FRANCISCO, CA, August 14, 2024 ‒ American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for stereotactic
Formation Minerals, Inc. Provides Fiscal Year End Corporate Update
Jacksboro, Texas, August 14, 2024 – Formation Minerals, Inc. (OTCQB: FOMI) (“Formation” or the “Company”), a growing oil and gas company with a focus on
American Shared Hospital Services Announces Second Quarter 2024 Earnings Conference Call
Call Scheduled for Today at 6:30 PM ET SAN FRANCISCO, August 14, 2024 – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading
Sono-Tek Announces Additional $2.95 Million Order from Specialty Clean Energy Customer
4 System Order Expected to be Shipped in Fiscal 2026 Company Experiencing Strong Demand from Clean Energy Sector MILTON, NY, August 13, 2024 — Sono-Tek
Metatron Announces QuantumBeam – A Revolution in AI-Controlled Energy Transmission
Dover, DE, August 13th, 2024 – Metatron Apps Inc (OTC: MRNJ) ($MRNJ), leading developer of over 1000 mobile apps proudly introduces QuantumBeam, a groundbreaking service
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Case Series represents second study showing VitaGraft Kidney as a measure of response to the benefit of therapy for one leading cause of allograft failure
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
POMPANO BEACH, FL, 2024 — BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics, reports
SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products
MIAMI, FL, August 12, 2024 – SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with
AB INTL GROUP Reports of Financial Results for period ending May 31, 2024 and achieved Net Profitability
NEW YORK, August 12, 2024 — AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces its financial
StemSation International Provides Corporate Updates
StemSation International is providing updates on corporate planning and direction as they execute on an expanded business model Plantation, Florida, August 12, 2024 – StemSation
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
Top Line Data Expected Year-End 2024 Pittsburgh, August 12, 2024 — Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” “we” or the “Company”), a clinical-stage
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
NEW YORK, NY, August 09, 2024 – ANEW MEDICAL, INC. (NASDAQ: WENA) has announced that, as a result of its worldwide licensing agreement with Teleost
Oncocyte Announces Successful GraftAssure Beta Launch and Q2 2024 Results
Interest in kidney transplant assay represents approximately 25% of US transplant volume Company lays out land and expand strategy in transplant IRVINE, Calif., August 8,
ANEW MEDICAL, INC. Announces Patents Issued in Major Asian Markets for use of Genetic Therapy in the Treatment of Alzheimer’s Disease and ALS
New York, NY, August 8, 2024 – ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a US-based biotechnology company focused on developing cell- and
Premier Graphene President Pedro Mendez Meets with Global Leader in Sustainable Construction
Premier’s Graphene Suspensions Receiving Interest from one of the World’s Largest Materials Handling Companies EL CENTRO, California, August 8, 2024 – Premier Graphene, Inc. (OTC
Contact Us
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850